Hancock Whitney Corp Alpine Immune Sciences, Inc. Transaction History

Hancock Whitney Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$8.19 - $11.31 $153,324 - $211,734	-18,721 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$8.81 - $15.03 $63,863 - $108,952	7,249 Added 63.19%	18,721 $168,000
Q3 2020 Nov 05, 2020	BUY	$7.15 - $11.5 $82,024 - $131,928	11,472 New	11,472 $101,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.